InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Gill David N, 董事. Director active across 4 companies, notably Strongbridge Biopharma plc. Cumulatively, 15 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €110k. History available since 14 May 2021. The latest transaction was filed on 17 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gill David N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
45,559 股0Common StockSEC:0001570562-26-000020:0
5,825 股@ US$8.60100.0% 占其流量Common StockSEC:0001106519-25-000005:0
25,080 股0Common StockSEC:0001415889-25-019046:0
7,364 股0Common StockSEC:0001570562-25-000039:0
3,495 股0Common StockSEC:0001104659-24-071399:0
3,643 股@ US$12.724739.0% 占其流量Common StockSEC:0001570562-24-000090:0
6,464 股0Common StockSEC:0001570562-24-000024:0
2,330 股0Common StockSEC:0001104659-23-070043:0
8,293 股0Common StockSEC:0001570562-23-000021:0
5,313 股@ US$13.0970.016% mcap100.0% 占其流量Common StockSEC:0001570562-22-000104:0
15,568 股0Common StockSEC:0001570562-22-000049:0
78,058 股Ordinary SharesSEC:0001179110-21-009277:0
17,763 股@ US$2.0646.0% 占其流量Ordinary SharesSEC:0001179110-21-009218:0
40,000 股0Ordinary SharesSEC:0001179110-21-005555:0
19,075 股@ US$2.3554.0% 占其流量Ordinary SharesSEC:0001179110-21-005441:0
15 条申报中的 15 条
About Gill David N
GILL DAVID N is Administrateur at Evolus, Inc., Y-mAbs Therapeutics, Inc. and Strongbridge Biopharma plc. He has 15 filings in total, and in the 15 most recent filings we hold, the transactions run from 2021-05-17 to 2026-02-19, with EUR 0 of buys and EUR 152186 of sells, and the most frequent transaction nature being Attribution.
